Are you ready? Update on new EU Clinical Trial Regulations.

The New Clinical Trials Regulation (CTR) EU No 536/2014: Update EUFEMED 2015

On 22^nd of May in Brussels during the 3^rd Joint Conference of European Human Pharmacological Societies the European Federation of Exploratory Medicines Development (EUFEMED) was inaugurated by the four European early clinical drug development organisations from Belgium (BAPU), France (Club Phase I), Germany (AGAH), and UK (AHPPI).

The conference comprised 2 pre-conference workshops as well as two full conference days with a multifaceted scientific programme on the theme of “European Competitiveness in Early Clinical Drug Development: threats and opportunities”.

One of the most exciting topics was the update on the new EU regulation; one workshop on this topic took place as well as a session on the first day of the conference. In short, the following update can be given:

• The functional specifications for the EU portal and EU database to be audited have been signed off by the Deputy Executive Director on 10^th of April 2015
• The first draft bill (Referentenentwurf) in Germany is planned for June 2015

This shows that the implementation of the new regulations is moving swiftly and it is crucial to consider these guidelines when planning future clinical trials.

To get a better overview of the implementation status you can find a summary on the implementation of the new regulations in Germany as presented by Thomas Sudhop from the Federal Institute for Drugs and Medical Devices (BfArM) on the 20^th of May, 2015. Also you can read this blog post for a better overview of the new regulations.

Sign up for the Profil Blog (enter your email on the right) if you want to receive updates from Profil on the implementation of the new trial regulations. Carrying out your clinical trials with Profil ensures that the dedicated regulatory team will make sure your study is always run according to most recent guidelines.